Like the CEO of any startup, Wendy Davis understands the challenges of taking a fledgling company and trying to grow it. That’s perhaps doubly true in the bioscience industry where access to affordable lab space and equipment are often essential to success.
“Science-based [startups] have unique needs,” said Davis, whose company is working to commercialize a diagnostic for preeclampsia, a potentially life threatening complication of pregnancy. “They need an environment so they don’t get bogged down in day-to-day support infrastructure [concerns] that can detract from accomplishing significant milestones.”
Davis, it seems, has found her company’s home: Groton-based CURE Innovation Commons, Connecticut’s latest bio-tech incubation lab designed to attract startups to and from within the state. The newest site — a $4.1 million, 22,000-square-foot facility — features 12 private and shared laboratories, 18 private and shared office suites, conference rooms, event space and office hours with mentor and industry experts.
The state’s latest innovation lab joins similar incubation centers in Hartford/Farmington and New Haven creating a bioscience triangle across the state, according to Stephen MacKenzie, executive director of the Southeastern Connecticut Economic Development Group, which supported the build out and promotion of CURE Commons.